Your account is not claimed yet. You can sign up with ORCID to claim your account.

Marco Folini

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Venues

Cancers

Journal of hematology & oncology

Cell death & disease

International journal of molecular sciences

Fondazione IRCCS Istituto Nazionale dei Tumori

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Istituto Nazionale dei Tumori Jan 9o 1997

Italy

Biologo :: Dipartimento di Oncologia Sperimentale e Medicina Molecolare

Publications

Natalia Maciejewska, Mateusz Olszewski, Jakub Jurasz, Maciej Baginski, Maryna Stasevych, Viktor Zvarych, Marco Folini, Nadia Zaffaroni
Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres. Cell death & disease 13 (11) (2022)
Irene Alessandrini, Stefano Percio, Eisa Naghshineh, Valentina Zuco, Silvia Stacchiotti, Alessandro Gronchi, Sandro Pasquali, Nadia Zaffaroni, Marco Folini
Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma. Cancers 14 (11) (2022)
Irene Alessandrini, Marta Recagni, Nadia Zaffaroni, Marco Folini
On the Road to Fight Cancer: The Potential of G-quadruplex Ligands as Novel Therapeutic Agents. International journal of molecular sciences 22 (11) (2021)
Marta Recagni, Joanna Bidzinska, Nadia Zaffaroni, Marco Folini
The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications. Cancers 12 (4) (2020)
Silvia Stacchiotti, Valentina Zuco, Monica Tortoreto, Denis Cominetti, Anna Maria Frezza, Stefano Percio, Valentina Indio, Marta Barisella, Valentina Monti, Silvia Brich, Annalisa Astolfi, Chiara Colombo, Sandro Pasquali, Marco Folini, Mrinal M Gounder, Maria A Pantaleo, Paola Collini, Angelo Paolo Dei Tos, Paolo Giovanni Casali, Alessandro Gronchi, Nadia Zaffaroni
Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft. Cancers 11 (7) (2019)
Graziella Cimino-Reale, Paolo Gandellini, Francesca Santambrogio, Marta Recagni, Nadia Zaffaroni, Marco Folini
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells. Journal of hematology & oncology 10 (1) (2017)

Marco Folini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Folini